Allergic Conjunctivitis
📧 Sign up to get email alerts when something new happens for Allergic Conjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Bepotastine Besilate Ophthalmic Solution for allergic conjunctivitis has completed with …
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis [Phase 2, Phase 3]
This clinical trial update reports results from Phase 2 and Phase 3 studies evaluating how quickly Bepotastine Besilate ophthalmic solution …
-
CLINICAL_TRIALS trial_result · 2012-03-21Clinical Trial Update: Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge [Phase 2]
Phase 2 randomized trial comparing Loteprednol Ophthalmic Base and Loteprednol Ophthalmic Suspension versus placebo in an allergen challenge…
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation [Phase 2]
Phase 2 trial evaluating the efficacy of coadministration of FOV1101-00 with Prednisolone Acetate in patients with mild ocular allergic infl…
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis [Phase 2]
A Phase 2 trial evaluating the efficacy of low- and high-dose cyclosporine with prednisolone acetate, compared to its components and vehicle…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC) [Phase 2]
A single-center Phase 2 randomized trial evaluated the duration of action of brimonidine tartrate ophthalmic solution for ocular redness cau…
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Twin SUBLIVAC® Grasses Clinical Efficacy Study [Phase 3]
Phase 3 clinical efficacy study of Twin SUBLIVAC Grasses for seasonal allergic rhinitis and allergic conjunctivitis. The study status is com…
-
CLINICAL_TRIALS trial_result · 2012-01-31Clinical Trial Update: Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients [Phase 4]
Phase 4 trial evaluating the effect and tolerance of preservative-free NAAGA on inflammatory components and symptoms of dry eye syndrome in …
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Safety and Efficacy Study of a Eye Drop for Eye Allergy [Phase 3]
Phase 3 study evaluating the safety and efficacy of an eye drop for allergic conjunctivitis completed, with trial results posted.
-
CLINICAL_TRIALS trial_result · 2011-09-27Clinical Trial Update: Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis [Phase 3]
Phase 3 clinical trial evaluating the efficacy of an ophthalmic solution for induced allergic conjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-27Clinical Trial Update: Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis [Phase 3]
A Phase 3 trial evaluating an ophthalmic solution for induced acute allergic conjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of sublingual immunotherapy with depigmented-polymerized pollen extracts for allergic rhi…
-
CLINICAL_TRIALS trial_result · 2011-07-11Clinical Trial Update: Comparison of Tolerability Between Two Allergy Drops [Phase 4]
This Phase 4 clinical trial update compares tolerability between two allergy eye drop formulations in allergic conjunctivitis.
-
CLINICAL_TRIALS trial_result · 2011-06-20Clinical Trial Update: Glycyphagus Domesticus Allergen Extract. Determination of the in Vivo Biological Activity in Histamine Equivalent Units (HEP). [Phase 2]
Phase 2 trial evaluating the in vivo biological activity of Glycyphagus domesticus allergen extract using histamine equivalent units (HEP) a…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses [Phase 4]
Phase 4 clinical trial update on BEPREVE (bepotastine besilate ophthalmic solution) 1.5% for allergic conjunctivitis. The study status is li…
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense [Phase 2]
Phase 2 trial evaluating depigmented and polymerized Phleum pratense allergen extract for allergic rhinitis, allergic conjunctivitis, and as…
-
CLINICAL_TRIALS trial_result · 2010-11-23Clinical Trial Update: Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers [Phase 3]
Phase 3 safety study of a ketotifen-delivering contact lens in healthy volunteers has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2010-11-23Clinical Trial Update: Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers [Phase 3]
Phase 3 safety study evaluating a ketotifen-containing contact lens in healthy volunteers to assess tolerability related to allergic conjunc…
-
CLINICAL_TRIALS trial_result · 2010-11-15Clinical Trial Update: Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy [Phase 2]
Phase 2 dose-finding trial of CYT003-QbG10 for house dust mite–induced rhinoconjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-05Clinical Trial Update: Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units [Phase 2]
Phase 2 trial assessing standardization and biological activity of Chortoglyphus Arcuatus Allergenic Extract for allergic rhinitis and aller…
-
CLINICAL_TRIALS trial_result · 2010-05-05Clinical Trial Update: Long-term Efficacy and Safety Study With Oralgen Grass Pollen [Phase 2, Phase 3]
The document announces the completion of a long-term efficacy and safety study (Phase 2/Phase 3) evaluating Oralgen Grass Pollen for allergi…
-
CLINICAL_TRIALS trial_result · 2010-03-15Clinical Trial Update: Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR) [Phase 4]
Phase 4 clinical trial evaluating olopatadine hydrochloride ophthalmic solution in seasonal allergic rhinitis using an OHIO chamber, with re…
-
CLINICAL_TRIALS trial_result · 2009-11-11Clinical Trial Update: Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers [Phase 3]
A Phase 3 safety study of Bepotastine Besilate Ophthalmic Solution was completed in normal volunteers, with results posted.
-
CLINICAL_TRIALS trial_result · 2009-05-27Clinical Trial Update: Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis [Phase 4]
Phase 4 trial update evaluating two marketed ocular anti-allergy medications in subjects with allergic conjunctivitis; results have been pos…
-
CLINICAL_TRIALS trial_result · 2009-04-27Clinical Trial Update: Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis [Phase 2]
A Phase 2 trial of an immunomodulatory therapy for adults with perennial allergic rhinitis and rhinoconjunctivitis due to house dust mite an…